Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics Read More


Ablexis Announces Perpetual License Agreement for AlivaMab Mouse with Janssen Read More

Developing a Next-Generation Platform for Antibody Drug Discovery - Innovative, genetically engineered mice will serve as a world-class platform for the discovery of human therapeutic antibodies.

Highly sought after by biotechnology and pharmaceutical companies, transgenic mice still offer the most productive platform for successful human antibody drug discovery and development. Ablexis’ innovative transgenic mouse platform provides the foundation for the efficient discovery and development of the next wave of therapeutic antibodies to treat human diseases.

Learn More